Catalyst Wire Dossier Catalyst Wire Dossier

Hanferon

· HanAll BioPharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hanferon, covering 2025-04-22 to 2025-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C [Phase 1, Phase 2]

See pricing